We targeted a GLP-1-RA concentration and dosage relevant to human equivalent dosing of semaglutide (clinical dosing of semaglutide is 1 mg weekly) ( 49, 50 ), for evaluation in a rat model of insulin-impaired diabetes
A mild sweet or fruity odor typically indicates nutritional ketosis from fat metabolism during weight loss, which is generally benign
All authors participated in critical review of the manuscript
Once in circulation, these fatty acids can be taken up by muscle tissue, cardiac tissue, and liver for beta-oxidation (burning for energy)
They may suggest: Lowering the dose or slowing the dosing schedule Avoiding foods that may trigger side effects (e.g., fatty foods triggering nausea) Managing symptoms through hydration, dietary changes, or injection timing Who shouldnt take retatrutide
These recommendations are based on results that showed that GLP-1RA compared with insulin therapy (basal, premixed, or intensified basal-bolus regimens) have similar or even better efficacy in HbA1c reduction and a lower hypoglycemia risk, promotes weight loss instead of weight gain, and reduces the burden of drug administration frequency and self-monitoring of blood glucose [1, 2]